When was Organix founded?

Organix was founded in 1986 and raised its 1st funding round 24 years after it was founded.

Where is Organix located?

Organix is headquartered in Woburn, United States.

How many employees does Organix have?

As of Jul 31, 2026, the latest employee count at Organix is 89.

Is Organix a funded company?

Organix is a funded company, having raised an undisclosed amount across 4 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on May 27, 2010.

When was the latest funding round of Organix?

Organix's latest funding was a $***** Grant (prize money) round on May 01, 2013, with participation from 1 investor. Its primary sector is Biopharma Outsourcing. In United States, the Biopharma Outsourcing sector has seen $678M in funding in 2026 to date.

Where does Organix rank among its competitors?

Organix ranks 22nd amongst 234 active competitors, of which 21 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was ChemLex, which secured $45M in Dec, 2025.

Who are the top competitors of Organix?

Organix's top competitors include Sai Life Sciences, NFIL and IRBM. Among them, ChemLex secured the most recent funding round in December, 2025.

Organix - 2026 Company Profile, Team, Funding & Competitors

Organix is an acquired company based in Woburn (United States), founded in 1986 by Howard Sard. It operates as a Custom synthesis, research chemicals, and CRO services for complex chemistry challenges. Organix has raised an undisclosed amount in funding. The company has 234 active competitors, including 21 funded and 31 that have exited. Its top competitors include companies like Sai Life Sciences, NFIL and IRBM.

Company Details

Custom synthesis, research chemicals, and CRO services for complex chemistry challenges. The company specializes in delivering solutions for organic and medicinal chemistry needs. They offer custom synthesis, analytical services, and contract R&D, with expertise in lipids, oligonucleotides, and polymer chemistry. Their services support breakthroughs across biotech, pharma, and materials science. They provide custom polymers and polymer nanoparticles for drug delivery, biomaterials, and advanced materials science. The company offers high-precision testing and characterization for quality control and compliance, process development, and medicinal chemistry services. They provide tailored compound synthesis to accelerate discovery and development, offering both fee-for-service and full-time equivalent research models to fit project needs.

Website: organixinc.com
Social
Email ID: *****@organixinc.com
Phone Number: +1 **********

Key Metrics

Founded Year

1986

Location

Woburn, United States

Stage

Acquired

Latest Funding Round

Grant (prize money), May 01, 2013, $*****

Investors

HHS & 1 more

Ranked

22^nd among 234 active competitors

Employee Count

89 as on Jul 31, 2026

Similar Companies

Sai Life Sciences & 271 more

Exit Details

Acquired by Symeres (Apr 26, 2022)

View Organix's full profile

Organix is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
organix inc CIN: 04-2938994 , United States, Active	Dec 31, 2007	-	44 (As on Dec 31, 2021)	-

Organix got acquired by Symeres on Apr 26, 2022.

Click here to take a look at Organix's acquisition in detail

Organix has raised funding over 4 rounds. Its first funding round was on May 27, 2010. Its latest funding round was a Grant (prize money) round on May 01, 2013 for $*****. 1 investor participated in its latest round. Organix has 2 institutional investors.

Here is the list of recent funding rounds of Organix:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 01, 2013	1799495	Grant (prize money)	8622785	4423520	8524027	9502665
Sep 17, 2011	9995780	Grant (prize money)	7921656	7797323	6266858	HHS
Sep 16, 2011	8411104	Grant (prize money)	2412395	9299051	8192083	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Organix's funding rounds and investors

The founders of Organix is Howard Sard.

Here are the details of Organix's key team members:

Howard Sard: Co-Founder of Organix.

View details of Organix's Founder profiles and Board Members

Organix's employee count trend

Organix has 89 employees as of Jul 26. Here is Organix's employee count trend over the years:

Uncover Organix's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Organix include Sai Life Sciences, NFIL and IRBM. Here is the list of Top 10 competitors of Organix, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sai Life Sciences 1999, Hyderabad (India), Public	Provider of drug discovery, development, and manufacturing of complex small molecules	$108M	HBM Healthcare Investments, Sequoia Capital ... & 123 others	66/100
2nd	NFIL 1967, Mumbai (India), Public	CRAMS company specialising in the custom chemical synthesis and manufacturing of fluorinated compounds	-	-	50/100
3rd	IRBM 2010, Pomezia (Italy), Funding Raised	Integrated drug discovery and preclinical development service provider	-	BioVaria, Europa	48/100
4th	Medicilon 2004, Pudong (China), Funding Raised	Integrated drug discovery and preclinical development services	-	Spinnotec, Fortune Capital & 1 others	47/100
5th	ChemLex Shanghai (China), Series B	Provider of consulting services in the field of chemical research and development through artificial intelligence chemical synthesis	$71M	LYFE Capital, Qiming Venture Partners & 3 others	46/100
6th	Bioduro 2005, San Diego (United States), Acquired	Global CRDMO providing integrated drug discovery, development, and manufacturing services	-	BridgeWest Group	45/100
7th	Alzheimer's Drug Discovery 1998, New York City (United States), Funding Raised	Foundation aims to discover drugs to prevent, treat, and cure alzheimer's disease	-	HHS	45/100
8th	48Hour Discovery 2017, Edmonton (Canada), Funding Raised	Developer of molecular discovery platform	-	Edmonton, K-Startup Grand Challenge	44/100
9th	Alfa Chemistry 2015, Ronkonkoma (United States), Unfunded	Supplier of research chemicals, reagents, custom synthesis, and analytical services	-	-	43/100
10th	Vernalis 1999, Wokingham (United Kingdom), Acquired	Drugs for the treatment of cough, asthma, migraine and cancer.	-	Invesco Mutual Fund, Thuja Capital & 4 others	43/100
22nd	Organix 1986, Woburn (United States), Acquired	Custom synthesis, research chemicals, and CRO services for complex chemistry challenges	-	HHS, United States Department of Agriculture	35/100